With over 200 delegates registered, the event will provide an opportunity for current and future industry partners to hear about successful industry-academic collaborations.

There will be a particular focus on PhD CASE Studentships – collaborative training grants that include a placement with the sponsoring company. These studentships provide an opportunity for collaborations between industry and academia and a valuable training environment for students.

The posters and an exhibition of research excellence across the Biomedical and Health Sciences will be open throughout the day, with industrial partnership project talks in the morning. Professor George Davey Smith from Bristol’s Medical Research Council Integrative Epidemiology Unit will round off the morning with a keynote speech entitled ‘Harnessing population genetics to improve understanding of pharmaceutical targets’.

Professor George Banting, Dean of Biomedical Sciences, said: "This day will provide an opportunity to develop further links between our academic research communities and colleagues in biotechnology and pharmaceutical industries.  It will also highlight the breadth of opportunities and expertise available via collaboration with fundamental bioscience and health researchers at the University of Bristol."

The event will culminate in a panel discussion, opened by David Bleakman, Executive Director and Chief Scientific Officer at Eli Lilly and Company, exploring academic-industrial collaboration and translational research.